PORTRAZZA (Necitumumab) Approved As First-Line Therapy For Metastatic, Squamous Non-Small Cell Lung Cancer, Available At Biologics, Inc. (NC)
CARY, N.C.--(BUSINESS WIRE)--Biologics, Inc., is pleased to announce that it has been selected by Lilly Oncology as the exclusive specialty pharmacy provider for PORTRAZZA™ (necitumumab).
In addition to accessing the drug via specialty distribution, Eli Lilly will offer physicians and healthcare practices the opportunity to order PORTRAZZA™ through Biologics’ specialty pharmacy as an alternative option.
PORTRAZZA™ is an epidermal growth factor receptor (EGFR) antagonist indicated in combination with gemcitabine and cisplatin, for first-line treatment of patients with metastatic squamous non-small cell lung cancer. It was approved by the U.S. Food and Drug Administration on November 24, 2015.
Biologics takes a high-touch approach to patient care, providing patient-specific support and individualized care plans for each patient to help manage side effects and foster adherence.
The team also works to navigate financial barriers to care by providing benefits investigation, prior authorization and copay assistance services. In 2014, the team helped secure over $29M in copay assistance for eligible patients.
Physicians may submit prescriptions to Biologics via phone (800.850.4306, option 2), fax (800.823.4506) or eScribe.
About Biologics: Biologics, Inc. is an oncology pharmacy services company that empowers healthcare providers, payors and biopharma to optimize cancer care for the best possible outcomes – clinical, financial and emotional. Unifying fragmented healthcare services, Biologics brings efficiency and humanity to oncology care management by focusing on the patient’s best interest as the surest path to managing cost and risk. Biologics is at the center of a rapidly changing oncology environment and supports patients across all treatment modalities, while providing clinical outcomes and informatics reporting that allow for informed decision making. Since it was founded in 1994, Biologics has been dedicated to improving the lives of those fighting cancer. Privately held, Biologics maintains headquarters and operations in Cary, North Carolina. Visit biologicsinc.com or follow us on Twitter (@BiologicsInc).